Longpei Chen

Comprehensive analysis of the regulatory network of differentially expressed mRNAs, lncRNAs and circRNAs in gastric cancer.

H. Cai, J. Xu, T. Han, 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Phase I trial of Claudin 18.2-specific chimeric antigen receptor T cells for advanced gastric and pancreatic adenocarcinoma.

J. Xu, Zonghai Li, Yingyi Zhang, 2019, Journal of Clinical Oncology.

ICOSL expressed in triple-negative breast cancer can induce Foxp3+ Treg cell differentiation and reverse p38 pathway activation.

D. Zhou, Yingyi Zhang, Jie Li, 2022, American journal of cancer research.

Long‐term prognostic significance of interleukin‐17‐producing T cells in patients with non‐small cell lung cancer

M. Tao, L. Miao, Longpei Chen, 2019, Cancer science.

Chimeric antigen receptor-natural killer cells: Novel insight into immunotherapy for solid tumors (Review)

Longpei Chen, Xianbao Zhan, Bin Wang, 2021, Experimental and Therapeutic Medicine.

Prevalence, trends, and outcomes of atrial fibrillation in hospitalized patients with metastatic cancer: findings from a national sample

Yang Cao, Longpei Chen, Cheng Wu, 2021, Cancer medicine.

Phase I trial of personalized mRNA vaccine encoding neoantigen in patients with advanced digestive system neoplasms.

Shuhui Tang, Jie Li, Longpei Chen, 2020 .